|Articles|September 1, 1997

The Treatment of Hypercholesterolemia: A Managed Care Perspective
Volume 3
Issue 8 Suppl

Managing Comorbidities through Cholesterol-Lowering

Author(s)Alan O. Marcus, MD

Download PDF: Managing Comorbidities through Cholesterol-Lowering

Articles in this issue

almost 29 years ago

Article

Goals and Objectives

almost 29 years ago

Article

Introduction

almost 29 years ago

Article

The Rationale for Treating Hypercholesterolemia

almost 29 years ago

Article

Lowering Risk Factors through Cholesterol Treatment: Overview of the Recent Major Trials

almost 29 years ago

Article

Preventing Coronary Heart Disease in the Managed Care Era: Improving the Cost Effectiveness of Lipid-Lowering Therapy with HMG-CoA Reductase Inhibitors

almost 29 years ago

Article

Treating Hyperlipidemia to Prevent Coronary Heart Disease: What Are the Treatment Goals and How Do We Get There?

almost 29 years ago

Article

CME Quiz

almost 29 years ago

Article

Selected Abstracts

almost 29 years ago

Article

Bibliography

almost 29 years ago

Article

Participants

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Managing Comorbidities through Cholesterol-Lowering

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Monoclonal Antibodies Had Varying Efficacy in Treating MG

How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA